Overview
Long-term Treatment on BAY77-1931 (Lanthanum Carbonate) to Measure Lanthanum Concentrations in Bone
Status:
Completed
Completed
Trial end date:
2008-10-01
2008-10-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
To measure lanthanum concentrations in bone in patients with hyperphosphatemia receiving dialysisPhase:
Phase 2Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Bayer
Criteria
Inclusion Criteria:- Patients undergoing dialysis or plan to start dialysis before the initial
administration of the study medication
Exclusion Criteria:
- Patients with severe hypocalcemia (adjusted serum calcium level of <7.5 mg/dL)